letterradar
All topics

The best China Healthcare newsletters

1 newsletters, ranked by editorial quality and how recently they published. Looking for something more specific? Search instead.

SinoDrugWatch

Ghost
sinodrugwatch.ghost.io· irregular· Inactive for over a year

SinoDrugWatch covers drug innovation linked to China and globally, in both Chinese and English. Its sample issues report recent regulatory approvals and licensing deals, such as an FDA adjuvant approval for a PD-1 inhibitor and a large China-based licensing agreement.

fda approvalcemiplimablibtayocutaneous squamous cell carcinomachina biotechlicensing deal
Subscribe Details 4/10